Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Carnahan

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Structure (London, England : 1993)|September 26, 2024
Discovery and characterization of a pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.
Nature Immunology|October 8, 2020
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Matthew C Woodruff, Richard P Ramonell, Doan C Nguyen, et al.
Cell Reports|January 28, 2023
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donorKelsey A Pilewski, Steven Wall, Simone I Richardson, et al.
Nature Communications|November 4, 2023
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathologyDaniel N Streblow, Alec J Hirsch, Jeffrey J Stanton, et al.
Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Structure (London, England : 1993)|September 26, 2024
Discovery and characterization of a pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.
Nature Immunology|October 8, 2020
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Matthew C Woodruff, Richard P Ramonell, Doan C Nguyen, et al.
Cell Reports|January 28, 2023
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donorKelsey A Pilewski, Steven Wall, Simone I Richardson, et al.
Nature Communications|November 4, 2023
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathologyDaniel N Streblow, Alec J Hirsch, Jeffrey J Stanton, et al.
Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Pageof 15